Pujol Jean-Louis, Godard Anne-Laure, Jacot William, Labauge Pierre
Hôpital Universitaire Arnaud de Villeneuve, Montpellier, France.
J Thorac Oncol. 2007 Feb;2(2):168-70. doi: 10.1097/jto.0b013e31802f1c9d.
Anti-Hu antibodies are directed against lung cancer cell antigens. The anti-tumor effect of anti-Hu antibodies has been suggested by several studies demonstrating that patients presenting with anti-Hu antibodies have a longer survival. In this case report, we suggest that the immunology of HuAb paraneplastic syndrome by itself could induce tumor response.